Cargando…

Is amisulpride associated less with neuroleptic malignant syndrome? Review and hypothesis

Detalles Bibliográficos
Autores principales:	Peritogiannis, Vaios, Kalampokis, Georgios, Lixouriotis, Charalampos
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2991845/ http://dx.doi.org/10.1186/1744-859X-9-S1-S158

Ejemplares similares

Mental Health Care Delivery for Older Adults in Rural Greece: Unmet Needs
por: Peritogiannis, Vaios, et al.
Publicado: (2019)

Recent Insights on Prevalence and Corelations of Hypoactive Delirium
por: Peritogiannis, Vaios, et al.
Publicado: (2015)

Acute pulmonary edema and transient leukopenia in haloperidol-induced neuroleptic malignant syndrome
por: Hsu, S-T, et al.
Publicado: (1998)

The use of amisulpride in schizophrenic patients with resistant symptomatology
por: Kalfas, Dimitrios, et al.
Publicado: (2010)

Parkinson disease and Neuroleptic withdrawal
por: Jambunathan, Stephen, et al.
Publicado: (2010)

The Greek version of the MacArthur competence assessment tool for treatment: reliability and validity. Evaluation of capacity for treatment decisions in Greek psychiatric patients
por: Bilanakis, Nikolaos, et al.
Publicado: (2013)

Neuroleptic Malignant Syndrome: A case report and a literature review
por: De Juan Viladegut, O., et al.
Publicado: (2022)

Electroconvulsive Therapy for Neuroleptic Malignant Syndrome: A case report
por: Osca Oliver, A., et al.
Publicado: (2023)

NEUROLEPTIC MALIGNANT SYNDROME
por: Jayesh, Kanabar
Publicado: (1997)

Neuroleptic malignant syndrome
por: Rajamani, Bino, et al.
Publicado: (2016)

Neuroleptic malignant syndrome
por: Tan, Carolyn Michelle, et al.
Publicado: (2023)

Amisulpride-induced late-onset rabbit syndrome: Case report and literature review
por: Gundogmus, I., et al.
Publicado: (2022)

Aripiprazole induced neuroleptic malignant syndrome: A Case report
Publicado: (2022)

Ziprasidone Associated Neuroleptic Malignant Syndrome
por: Bell, Jeffrey D., et al.
Publicado: (2021)

Neuroleptic malignant syndrome induced by atypical neuroleptics and responsive to lorazepam
por: Yacoub, Adeeb, et al.
Publicado: (2006)

THE POSSIBILITY OF THE EVOLUTION OF NEUROLEPTIC MALIGNANT SYNDROME DURING THE CONCOMITANT USE OF CLOZAPINE WITH LITHIUM SALTS
por: Tomcuk, A., et al.
Publicado: (2023)

Neuroleptic Malignant Syndrome Associated with Valproate in an Adolescent
por: Yıldırım, Veli, et al.
Publicado: (2017)

Malignant Catatonia Versus Neuroleptic Malignant Syndrome
por: Desai, Saral, et al.
Publicado: (2021)

Resolution of symptoms in neuroleptic malignant syndrome
por: Pereira, Yvonne D.S., et al.
Publicado: (2010)

Risk Factors in Neuroleptic Malignant Syndrome
por: Gupta, Vinay, et al.
Publicado: (2003)

Olanzapine induced neuroleptic malignant syndrome
por: Patra, Bichitra Nanda, et al.
Publicado: (2013)

Olanzapine-Induced Neuroleptic Malignant Syndrome
por: Hosseini, Seyedhamze, et al.
Publicado: (2017)

Olanzapine-induced Neuroleptic Malignant Syndrome
por: Saha, Pradeep Kumar, et al.
Publicado: (2017)

Clozapine Induced Neuroleptic Malignant Syndrome
por: Jo, Yong Suk, et al.
Publicado: (2017)

The need for efficient long-term neuroleptic treatment in schizophrenic patients and the place of long acting injectable antipsychotics
por: Möller, Hans-Jurgen
Publicado: (2010)

INCREASED RISK OF OCCURRENCE OF NEUROLEPTIC MALIGNANT SYNDROME ON COMBINED TREATMENT WITH LITHIUM AND NEUROLEPTIC
por: Alexander, P. John, et al.
Publicado: (1997)

Priapism secondary to antipsychotic treatments with favorable response to amisulpride
por: Pérez Balaguer, A., et al.
Publicado: (2022)

Neuroleptic malignant syndrome associated with second-generation antipsychotics (SGA): An analysis of reported cases in eudravigilance database, 2017-2020
por: Torres, A., et al.
Publicado: (2021)

Case report on clozapine-associated neuroleptic malignant syndrome
por: Wang, Yanqiong, et al.
Publicado: (2012)

Atypical Neuroleptic Malignant Syndrome Associated with Use of Clozapine
por: Leonardo, Quevedo-Florez, et al.
Publicado: (2017)

Neuroleptic malignant syndrome associated with COVID-19 vaccination
por: Nagamine, Takahiko
Publicado: (2021)

Olanzapine-associated neuroleptic malignant syndrome: Is there an overlap with the serotonin syndrome?
por: Kontaxakis, Vassilis P, et al.
Publicado: (2003)

PM391. THE USE OF AMISULPRIDE IN TREATMENT OF PATIENTS WITH RESIDUAL SCHIZOPHRENIA
por: Janjic, Vladimir, et al.
Publicado: (2016)

Managing an effective treatment for neuroleptic malignant syndrome
por: Reulbach, Udo, et al.
Publicado: (2007)

NEUROLEPTIC MALIGNANT SYNDROME - A CASE REPORT
por: De souza, Joaquim Victor, et al.
Publicado: (1986)

NEUROLEPTIC MALIGNANT SYNDROME : REPORT OF 2 CASES
por: Deshmukh, D.K., et al.
Publicado: (1989)

THE NEUROLEPTIC MALIGNANT SYNDROME : REPORT OF THREE CASES
por: Sharma, R.C., et al.
Publicado: (1996)

A case of recurrent neuroleptic malignant syndrome
por: Ouyang, Zexiang, et al.
Publicado: (2013)

Two unusual complications of neuroleptic malignant syndrome
por: Ahmad, A., et al.
Publicado: (2013)

Neuroleptic malignant syndrome: A diagnostic challenge
por: Ambulkar, Reshma P, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_n32d4vfsdgcpl1q86aqkc2o8t6